NURO  Neurometrix Inc.

Exchange

NASDAQ

Sector

Health Care

Industry

Medical/Dental Instruments

Market Cap.

4.5M

Erratic Net Profit Margins over the past 10 years

NURO has had highly erratic net profit margins which are a great cause for concern. This company may operate in a highly volatile industry, or it may just have poor performance. Look at reasons for this inconsistency to understand if there is any reason to look past it.
Figures in USD. Fiscal year ends in December
2002200320042005200620072008200920102011
Net Income -4.79M -3.67M -4.28M 938,258.00 4.27M -8.38M -27.73M -11.92M -16.89M -9.98M
divided by
Revenue 4.23M 9.17M 17.92M 34.30M 55.25M 44.62M 31.12M 26.14M 13.90M 10.40M
Net Profit Margin -113.45% -40.00% -23.91% 2.74% 7.72% -18.78% -89.10% -45.60% -121.52% -96.00%

Strong Pricing Power over the past 10 years

NURO has maintained substantial gross margins, suggesting that they have been able to set prices without consideration of the cost of goods sold. This potentially leaves flexibility in inflationary environments to raise prices on consumers and maintain profitability.

$68.78 of every $100 worth of sales have been Gross Profit, on average over the past 10 years.
Figures in USD. Fiscal year ends in December
2002200320042005200620072008200920102011
Gross Profit 2.85M 6.46M 13.07M 25.44M 41.69M 32.56M 22.11M 18.60M 6.85M 6.52M
divided by
Revenue 4.23M 9.17M 17.92M 34.30M 55.25M 44.62M 31.12M 26.14M 13.90M 10.40M
Gross Margin 67.57% 70.48% 72.92% 74.17% 75.46% 72.97% 71.04% 71.17% 49.28% 62.70%

Medium Capital Intensity over the past 10 years

NURO has used a reasonable amount of their financial resources to invest in facilities and equipment required to produce its goods and services. This isn't perfect, but it shouldn't be an area of concern unless this number is strongly trending upwards.

32.59% of Profits are being spent on Capital Expenditures, like Property, Plant, & Equipment, required to run the business.
Figures in USD. Fiscal year ends in December
2002200320042005200620072008200920102011
Capital Expenditure 29,922.00 203,611.00 545,158.00 475,124.00 620,540.00 257,520.00 529,872.00 342,115.00 306,451.00 110,987.00
divided by
Net Income -4.79M -3.67M -4.28M 938,258.00 4.27M -8.38M -27.73M -11.92M -16.89M -9.98M
Capital Expenditure Ratio -0.62% -5.55% -12.73% 50.64% 14.54% -3.07% -1.91% -2.87% -1.81% -1.11%